CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands		Total	Series A redeemable convertible preferred stock	Series B redeemable convertible preferred stock	Series B-1 redeemable convertible preferred stock	Series B-2 redeemable convertible preferred stock	Common stock		Additional paid in capital	Accumulated deficit	Notes receivable - shareholder’s	Accumulated comprehensive income (loss)
Beginning balance, redeemable convertible preferred stock (in shares) at Dec. 31, 2019			16,620,000	14,213,000	5,416,000	0
Beginning balance, redeemable convertible preferred stock at Dec. 31, 2019			$ 14,970	$ 27,371	$ 14,786	$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of preferred stock (in shares)						18,199,000
Issuance of preferred stock						$ 53,085
Preferred stock issuance costs						$ (706)
Ending balance, redeemable convertible preferred stock (in shares) at Dec. 31, 2020			16,620,018	14,213,431	5,416,551	18,198,891
Ending balance, redeemable convertible preferred stock at Dec. 31, 2020			$ 14,970	$ 27,371	$ 14,786	$ 52,379
Beginning balance, common stock (in shares) at Dec. 31, 2019	[1]						16,039,000
Beginning balance, common stock at Dec. 31, 2019		$ (54,454)					$ 1		$ 2,483	$ (56,938)	$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock option and stock awards plans (in shares)	[1]						735,000
Issuance of common stock under employee stock option and stock award plans		32					$ 1		31
Issuance of warrants		16							16
Stock-based compensation expense related to employee stock awards		1,027							1,027
Foreign currency translation adjustment		(1)										(1)
Net loss		$ (19,044)								(19,044)
Ending balance, common stock (in shares) at Dec. 31, 2020		16,774,044					16,774,000	[1]
Ending balance, common stock at Dec. 31, 2020		$ (72,424)					$ 2		3,557	(75,982)	0	(1)
Ending balance, redeemable convertible preferred stock (in shares) at Dec. 31, 2021			0	0	0	0
Ending balance, redeemable convertible preferred stock at Dec. 31, 2021			$ 0	$ 0	$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock option and stock awards plans (in shares)	[1]						6,331,000
Issuance of common stock under employee stock option and stock award plans		517					$ 1		1,699		(1,183)
Reverse recapitalization on October 19, 2021 (in shares)			(16,620,000)	(14,213,000)	(5,416,000)	(18,199,000)	99,375,000	[1]
Reverse recapitalization on October 19, 2021		250,773	$ (14,970)	$ (27,371)	$ (14,786)	$ (52,379)	$ 12		250,761
Stock-based compensation expense related to employee stock awards		$ 39,404							39,404
Rescission of common stock awards (in shares)	[1]	(4,729,000)
Rescission of common stock awards		$ (48)							(1,231)		1,183
Foreign currency translation adjustment		(1)										(1)
Net loss		$ (152,685)								(152,685)
Ending balance, common stock (in shares) at Dec. 31, 2021		117,750,608					117,751,000	[1]
Ending balance, common stock at Dec. 31, 2021		$ 65,536					$ 15		$ 294,190	$ (228,667)	$ 0	$ (2)

[1] Retroactively restated to give effect to the October 19, 2021 reverse recapitalization.